Human neutralizing human immunodeficiency virus type 2-specific Fab molecules generated by phage display

Journal of General Virology

Volumn 80, Issue 8, 1999, Pages 1987-1993

  Björling, Ewa ^a   Von Garrelts, Eva ^b   Mörner, Andreas ^a   Ehnlund, Mariethe ^a   Persson, Mats A A ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 2; MOLECULAR CLONING; PHAGE DISPLAY; PHAGEMID; PRIORITY JOURNAL; VIRUS ENVELOPE;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; MACACA; RNA VIRUSES;

EID: 0344117546     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-8-1987     Document Type: Article

References (40)

1. Albert, J., Bredberg-Rådén, U., Chiodi, F., Böttiger, B., Fenyö, E.-M., Norrby, E. & Biberfeld, G. (1987). A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Research and Human Retroviruses 3, 3-10.
2. Albert, J., Stålhandske, P., Marquina, S., Karis, J., Fouchier, R. A., Norrby, E. & Chiodi, F. (1996). Biological phenotype of HIV type 2 isolates correlates with V3 genotype. AIDS Research and Human Retroviruses 12, 821-828.
3. Barbas, C. F., III & Lerner, R. A. (1991). Combinatorial libraries on the surface of phage (Phabs): rapid selection of antigen-specific Fabs. Methods (supplement to Methods in Enzymology) 2, 119-124.
4. Barbas, C. F., III, Kang, A. S., Lerner, R. A. & Benkovic, S. J. (1991). Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proceedings of the National Academy of Sciences, USA 88, 7978-7982.
5. Barbas, C. F., III, Hu, D., Dunlop, N., Sawyer, L., Cababa, D., Hendry, R. M., Nara, P. L. & Burton, D. R. (1994). In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proceedings of the National Academy of Sciences, USA 91, 3809-3813.
6. Björling, E., Broliden, K., Bernardi, D., Utter, G., Thorstensson, R., Chiodi, F. & Norrby, E. (1991). Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proceedings of the National Academy of Sciences, USA 88, 6082-6086.
7. Björling, E., Chiodi, F., Utter, G. & Norrby, E. (1994). Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2. Journal of Immunology 152, 1952-1959.
8. Böttiger, B., Karlsson, A., Andreasson, P. Å., Naucler, A., Mendes Costa, C. & Biberfeld, G. (1989). Cross-neutralizing antibodies against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a new isolate SBL-K135). AIDS Research and Human Retroviruses 5, 525-533.
9. Böttiger, B., Karlsson, A., Andreasson, P. Å., Naucler, A., Mendes Costa, C., Norrby, E. & Biberfeld, G. (1990). Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site. Journal of Virology 64, 3492-3499.
10. Burton, D. R., Barbas, C. F., III, Persson, M. A. A., Koenig, S., Chanock, R. M. & Lerner, R. A. (1991). A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proceedings of the National Academy of Sciences, USA 88, 10134-10137.
11. Cavacini, L. A., Emes, C. L., Power, J., Underdahl, J., Goldstein, R., Mayer, K. & Posner, M. R. (1993). Loss of serum antibodies to a conformational epitope of HIV-1/gp120 identified by a human monoclonal antibody is associated with disease progression. Journal of Acquired Immune Deficiency Syndromes 6, 1093-1102.
12. Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorophorm extraction. Analytical Biochemistry 162, 156-159.
13. Clavel, F., Guetard, D., Brun-Vezinet, F., Chamaret, S., Rey, M. A., Santos-Ferreira, M. O., Laurent, A. G., Dauguet, C., Katlama, C., Rouzioux, C., Klatzmann, D., Champalimaud, J. L. & Montagnier, L. (1986). Isolation of a new human retrovirus from West African patients with AIDS. Science 233, 343-346.
14. Collet, T. A., Roben, P., O'Kennedy, R., Barbas, C. F., III, Burton, D. R. & Lerner, R. A. (1992). A binary plasmid system for shuffling combinatorial antibody libraries. Proceedings of the National Academy of Sciences, USA 89, 10026-10030.
15. Hultman, T., Ståhl, S., Hornes, E. & Uhlén, M. (1989). Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Research 17, 4937-4946.
16. Kang, A. S., Burton, D. R. & Lerner, R. A. (1991 a). Combinatorial immunoglobulin libraries in phage lambda. Methods (supplement to Methods in Enzymology) 2, 111-118.
17. Kang, C. Y., Nara, P., Chamat, S., Caralli, V., Ryskamp, T., Haigwood, N., Newman, R. & Kohler, H. (19916). Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proceedings of the National Academy of Sciences, USA 88, 6171-6175.
18. Kanki, P. J., M'Boup, S., Ricard, D., Barin, F., Denis, F., Boye, C., Sangare, L., Travers, K., Albaum, M., Marlink, R., Romet-Lemonne, J.-L. & Essex, M. (1987). Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa. Science 236, 827-831.
19. Kent, K. & Björling, E. (1997). B-cell epitopes in the envelope glycoproteins of HIV-2 and SIV. In HIV Molecular Immunology Database 1996, pp. IV-1-IV-17. Edited by B. T. M. Korber, B. D. Walker, J. P. Moore & G. Myers. Los Alamos, NM : Los Alamos National Laboratory.
20. Kent, K. A., Powell, C., Corcoran, T., Jenkins, A., Almond, N., Jones, I., Robinson, J. & Stott, E. J. (1993). Characterization of neutralizing epitopes of simian immunodeficiency virus envelope using monoclonal antibodies. In Proceedings of the Huitième Colloque des Cent Gardes, pp. 167-172.
21. Lum, L. G., Burns, E., Janson, M. M., Martin, P. J., Giddings, B. R., Seigneuret, M. C., Noges, J. E. & Galoforo, S. C. (1990). IgG anti-tetanus toxoid antibody synthesis by human bone marrow. I. Two distinct populations of marrow B cells and functional differences between marrow and peripheral blood B cells. Journal of Clinical Immunology 10, 255-264.
22. McKeating, J. A., Thali, M., Furman, C., Karwowska, S., Gorny, M. K., Cordell, J., Zolla-Pazner, S., Sodroski, J. & Weiss, R. A. (1992). Amino acid residues of the human immunodeficiency virus type 1 gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. Virology 190, 134-142.
23. McKnight, Á., Shotton, C., Cordell, J., Jones, I., Simmons, G. & Clapham, P. R. (1996). Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein. Journal of Virology 70, 4598-4606.
24. Matsushita, S., Matsumi, S., Yoshimura, K., Morikita, T., Murakami, T. & Takatsuki, K. (1995). Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120. Journal of Virology 69, 3333-3340.
25. Moore, J. P. & Ho, D. D. (1995). HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS 9 (Suppl. A), S117-S136.
26. Nakamura, G. R., Byrn, R., Rosenthal, K., Porter, J. P., Hobbs, M. R., Riddle, L., Eastman, D. J., Dowbenko, D., Gregory, T., Fendly, B. M. & Berman, P. W. (1992). Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates. AIDS Research and Human Retroviruses 8, 1875-1885.
27. Norrby, E., Putkonen, P., Böttiger, B., Utter, G. & Biberfeld, G. (1991). Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1. AIDS Research and Human Retroviruses 7, 279-285.
28. Parren, P. W. & Burton, D. R. (1997). Antibodies against HIV-1 from phage display libraries: mapping of an immune response and progress towards antiviral immunotherapy. Chemical Immunology 65, 18-56.
29. Posner, M. R., Cavacini, L. A., Emes, C. L., Power, J. & Byrn, R. (1993). Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. Journal of Acquired Immune Deficiency Syndromes 6, 7-14.
30. Ranki, A., Weiss, S. H., Valle, S. L., Antonen, J. & Krohn, K. J. E. (1987). Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins. Clinical and Experimental Immunology 69, 231-239.
31. Rath, S., Stanley, C. M. & Steward, M. W. (1988). An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity. Journal of Immunological Methods 106, 245-249.
32. Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989). Molecular Cloning : A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
33. Samuelsson, A., Chiodi, F., Öhman, P., Putkonen, P., Norrby, E. & Persson, M. A. A. (1995). Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virus. Virology 207, 495-502.
34. Samuelsson, A., Yari, F., Hinkula, J., Ersoy, O., Norrby, E. & Persson, M. A. A. (1996). Human antibodies from phage libraries: neutralizing activity against human immunodeficiency virus type 1 equally improved after expression as Fab and IgG in mammalian cells. European Journal of Immunology 26, 3029-3034.
35. Steimer, K. S., Scandella, C. J., Skiles, P. V. & Haigwood, N. L. (1991). Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120. Science 254, 105-108.
36. Thali, M., Furman, C., Ho, D. D., Robinson, J., Tilley, S., Pinter, A. & Sodroski, J. (1992). Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. Journal of Virology 66, 5635-5641.
37. Thorstensson, R., Walther, L., Putkonen, P., Albert, J. & Biberfeld, G. (1991). A capture enzyme immunoassay for detection of HIV-2/SIV antigen. Journal of Acquired Immune Deficiency Syndromes 4, 374-379.
38. Weiss, R. A., Clapham, P. R., Weber, J., Cheingsong-Popov, R., Dalgleish, A., Carne, C. A., Weller, I.V. & Tedder, R. S. (1985). Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature 316, 69-72.
39. Weiss, R. A., Clapham, P. R., Weber, J. N., Whitby, D., Tedder, R. S., O'Connor, T., Chamaret, S. & Montagnier, L. (1988). HIV-2 antisera cross-neutralize HIV-1. AIDS 2, 95-100.
40. Williamson, R. A., Burioni, R., Sanna, P. P., Partridge, L. J., Barbas, C. F., III & Burton, D. R. (1993). Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proceedings of the National Academy of Sciences, USA 90, 4141-4145.